Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-10-18Clinical Trial Update: Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating preoperative chemotherapy for patients with early triple-negative breast cancer or HER2-positive operable …
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes [Phase 2]
Phase II pilot study evaluating cisplatin with metronomic cyclophosphamide in metastatic, stage IV triple-negative breast cancer resistant t…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer [Phase 1, Phase 2]
This update reports on a Phase 1/2 trial evaluating weekly paclitaxel, carboplatin, and bevacizumab as first-line therapy for triple-negativ…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers [Phase 1]
Phase 1 safety study of MM-121 in combination with cetuximab and irinotecan in patients with advanced cancers, including colorectal cancer a…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer [Phase 2]
A randomized Phase 2 neoadjuvant study comparing weekly paclitaxel with or without the SMAC mimetic LCL161 in triple-negative breast cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and radiation before surgery for triple-negative breast cancer was terminated; results were posted in …
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial examining cellular immune adjuvant therapy for triple-negative breast cancer, sponsored by First Affiliated Hospital Xi'an J…
-
CLINICAL_TRIALS research · 2016-08-08Clinical Trial Update: A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.
A pilot study is ongoing to monitor natural killer cells and circulating tumor cells in women previously treated for non-metastatic triple-n…
-
CLINICAL_TRIALS withdrawal · 2016-07-26Clinical Trial Update: Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer [Phase 1]
A Phase 1 trial of talazoparib in combination with the HSP90 inhibitor AT13387 for metastatic advanced solid tumors and recurrent ovarian, f…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Cabozantinib for Metastatic Triple Negative BrCa [Phase 2]
A Phase 2 study of cabozantinib in metastatic triple-negative breast cancer has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2016-05-30Clinical Trial Update: A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer [NA]
A pilot preoperative trial of ganetespib with paclitaxel for triple-negative breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial update of bevacizumab with gemcitabine and carboplatin in participants with triple-negative metastatic breast cancer; results …
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Phase II ABT-888 With Cyclophosphamide [Phase 2]
Phase II trial evaluating veliparib (ABT-888) in combination with cyclophosphamide across ovarian and related gynecologic cancers; results w…
-
CLINICAL_TRIALS withdrawal · 2016-04-29Clinical Trial Update: Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer [Phase 2]
A Phase 2 biomarker study of PF-03084014 in chemoresistant triple-negative breast cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib [Phase 2]
A Phase 2 clinical trial update evaluating afatinib in combination with paclitaxel as neoadjuvant therapy for triple-negative breast cancer,…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating tivantinib for recurrent or metastatic breast cancer has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating INIPARIB in combination with chemotherapy for triple-negativ…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating azacitidine in combination with entinostat in advanced breast cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating standard chemotherapy plus BSI-201 (iniparib) as neoadjuvant therapy for triple-negative breast cancer has comple…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial of bevacizumab plus paclitaxel and capecitabine in triple-negative metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating weekly cilengitide in combination with paclitaxel in adults with advanced, unresectable solid tumors, including bre…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating preoperative MM-121 with Paclitaxel in HER2-negative breast cancer completed; results were posted in 2016.
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial update evaluating neoadjuvant docetaxel with or without selumetinib in patients with triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer [Phase 2, Phase 3]
This update reports on a Phase 2/Phase 3 trial evaluating the addition of carboplatin to neoadjuvant therapy for patients with triple-negati…
-
CLINICAL_TRIALS research · 2016-02-15Clinical Trial Update: Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients [Phase 2]
Phase 2 trial update on olaparib (Lynparza) for locally advanced triple-negative breast cancer and locally advanced germline BRCA mutation–p…